{"abstract": "The F.D.A. rejected Arcoxia because of concerns that the drug could cause as many as 30,000 heart attacks a year if widely used.", "web_url": "https://www.nytimes.com/2007/04/12/business/12cnd-drug.html", "snippet": "The F.D.A. rejected Arcoxia because of concerns that the drug could cause as many as 30,000 heart attacks a year if widely used.", "lead_paragraph": "GAITHERSBURG, Md., April 12 \u2014 A panel of federal drug advisers voted 20-to-1 today to reject an application by Merck to sell its pain pill Arcoxia because of concerns that the drug could cause as many as 30,000 heart attacks a year if widely used.", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Panel Rejects Merck Pain Pill in 20-1 Vote", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Panel Rejects Merck Pain Pill in 20-1 Vote", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 3, "major": "N"}], "pub_date": "2007-04-12T04:00:00+0000", "document_type": "article", "news_desk": "ContinuousNews", "section_name": "Business Day", "byline": {"original": "By Gardiner Harris", "person": [{"firstname": "Gardiner", "middlename": null, "lastname": "Harris", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/b2da8f8a-df38-5f27-8ea6-2e149389c8c6", "word_count": 878, "uri": "nyt://article/b2da8f8a-df38-5f27-8ea6-2e149389c8c6"}